SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Vectren Corporation (VVC) trades at a trailing P/E of 0.1. Trailing earnings yield is 1,000.00%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (1,000.00%).
- Trailing Earnings Yield 1,000.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 71/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VVC
Valuation Multiples
P/E (TTM)0.1
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.67
Book Value / Share$0.00
Revenue / Share$6.81
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1,000.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2008 |
$0.54 |
$864.96M |
$43.9M |
5.1% |
| 2009 |
$1.64 |
$2.09B |
$133.1M |
6.4% |
| 2010 |
$1.64 |
$2.13B |
$133.7M |
6.3% |
| 2011 |
$0.85 |
$731.31M |
$69.7M |
9.5% |
| 2012 |
$1.94 |
$2.23B |
$159M |
7.1% |
| 2013 |
$1.66 |
$2.49B |
$136.6M |
5.5% |
| 2014 |
$0.47 |
$680.41M |
$39.16M |
5.8% |
| 2015 |
$2.39 |
$2.43B |
$197.3M |
8.1% |
| 2016 |
$2.55 |
$2.45B |
$211.6M |
8.6% |
| 2017 |
$0.67 |
$565M |
$55.68M |
9.9% |
